ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
HCKT
The Hackett Group, Inc.
HCKT has the edge over ASTS overall, supported by lower modeled downside and stronger valuation.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HCKT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| Stable | |
| Stable |
HCKT's profitability is currently strong, and its cash flow and balance sheet are stable, but its revenue is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
HCKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.7x | $13.44 | — |
| Cheap | 16x | $11.45 | -15% |
| Current | 19x | $13.44 | — |
| Fair | 21x | $14.55 | +8.2% |
| Expensive | 39x | $26.96 | +101% |
Historical ranges are pointers, not guarantees.
HCKT's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 8.7x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
HCKT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect HCKT's earnings to grow and its profitability to improve, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
HCKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.55 | +121% |
| Q3 2026 | $0.70 | +84% |
| Q2 2026 | $0.65 | +8.3% |
| Q1 2026 | $0.53 | -38% |
| Q4 2025 | $0.47 | -56% |
| Q3 2025 | $0.38 | -69% |
| Q2 2025 | $0.60 | -52% |
| Q1 2025 | $0.85 | -33% |
| Q4 2024 | $1.06 | -15% |
HCKT has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over HCKT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
HCKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $69.8M | -4.5% |
| Q2 2026 | $69.3M | -12% |
| Q1 2026 | $68.8M | -12% |
| Q4 2025 | $75.8M | -4.4% |
| Q3 2025 | $73.1M | -8.4% |
| Q2 2025 | $78.9M | +1.6% |
| Q1 2025 | $77.9M | +0.9% |
| Q4 2024 | $79.2M | +9.4% |
HCKT's revenue is shrinking: $70M last quarter, down 4.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.3 points |
| Q2 2026 | 11% | +5.3 points |
| Q1 2026 | 13% | +7.3 points |
| Q4 2025 | 12% | +2.2 points |
| Q3 2025 | 7.5% | -8.6 points |
| Q2 2025 | 5.8% | -10 points |
| Q1 2025 | 5.7% | -9.3 points |
| Q4 2024 | 9.8% | -6.1 points |
HCKT has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
HCKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.3M | -115% |
| Q2 2026 | $12.6M | +237% |
| Q1 2026 | -$7.5M | -382% |
| Q4 2025 | $17.1M | -13% |
| Q3 2025 | $9M | -3.9% |
| Q2 2025 | $3.7M | -71% |
| Q1 2025 | $2.7M | +44% |
| Q4 2024 | $19.6M | -21% |
HCKT has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
HCKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -213K shares |
| 1 year | -9.6% | -2.7M shares |
| 3 years | -10% | -2.9M shares |
| 5 years | -24% | -7.9M shares |
| Available history | -23% | -7.5M shares |
HCKT has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.8M |
| Q2 2026 | $3.9M |
| Q1 2026 | $3M |
| Q4 2025 | $41.2M |
| Q3 2025 | $17.4M |
| Q2 2025 | $4.3M |
| Q1 2025 | $6.2M |
| Q4 2024 | $3.6M |
HCKT spent $50M buying back its own shares over the past year, up 58% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HCKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.0x | Moderate |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | -0.1x | Net Cash |
HCKT's net debt is about 1.9 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
HCKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.5 | Neutral |
| Stochastic | 84.5 | Overbought |
HCKT's weekly RSI is 60 (neutral) and its Stochastic is 84 (overbought).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
HCKT PE vs Technology Sector
| Metric | HCKT | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 28x | 31% below |
| PE % | 38 | 35 | 3 pts above |
HCKT is trading at 19x earnings, a 31% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
HCKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 13% above |
| 20 week MA | $11.2 | 20% above |
| 50 week MA | $13.3 | 1% above |
| 100 week MA | $19.0 | 29% below |
| 200 week MA | $21.0 | 36% below |
HCKT has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
HCKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.9 | $14.0 | -12% |
| 2021 | $14.0 | $20.7 | +47% |
| 2022 | $20.7 | $20.5 | -0.8% |
| 2023 | $20.5 | $22.8 | +11% |
| 2024 | $22.8 | $30.9 | +36% |
| 2025 | $30.9 | $20.0 | -35% |
| 2026 YTD | $20.0 | $13.4 | -33% |
HCKT has the edge over ASTS on returns for 2026, with the stronger performance.